Cardiogenic Acute Pulmonary Edema in Subjects Over 75 Years Old: Impact of Non-invasive Ventilation on Mortality

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06107257

Acronym

CAPE

Enrollment

200

Registered

2023-10-30

Start date

2023-02-01

Completion date

2023-12-31

Last updated

2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Pulmonary Edema

Keywords

Cardiogenic Pulmonary Edema, Acute pulmonary edema, Non-invasive ventilation

Brief summary

People aged over 75 represent almost 10% of the general population, and 12 to 14% of patients consulting emergency departments. Cardiogenic acute pulmonary edema (APO) is a very common reason for admission to the emergency room. The effectiveness of non-invasive ventilation (NIV) has been demonstrated during the management of PAO and would allow, compared to medical treatment alone, a more rapid improvement in clinical and gasometric parameters as well as a reduction in the need for ventilation. orotracheal intubation. On the other hand, the impact of NIV on mortality in cardiogenic PAO seems poorly defined, with lower levels of scientific evidence regarding a possible benefit in terms of survival, particularly in the elderly population. The objective of this study is to determine whether the use of NIV in cardiogenic PAO in elderly subjects admitted to the emergency room of Strasbourg University Hospital would have an impact in terms of mortality up to 6 months compared to medical treatment alone.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

76 Years to No maximum

Inclusion criteria

* Adult subject (\> 75 years old) * Admission to the NHC emergency room between January 1, 2021 and October 31, 2021 * Diagnosis of cardiogenic PAO * Indication of NIV according to current recommendations * Subject not opposing the reuse of their data for scientific research purposes.

Exclusion criteria

* Subject having expressed his opposition to the reuse of his data for scientific research purposes. * Presence of an absolute contraindication to NIV * Respiratory distress due to pneumonia or other diagnosis * RT-PCR Sars Cov 2 positive in emergency

Design outcomes

Primary

Measure	Time frame
Survival Analysis	6 months after cardiogenic acute pulmonary edema

Countries

France

Contacts

Primary ContactElise SCHMITT, MD

elise.schmitt@chru-strasbourg.fr33 3 88 11 58 84

Outcome results